Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $636K | $858K |
| Revenue growth | — | — | — | — | — | 34.9% |
| Operating income | -$25.3M | -$45.6M | -$67.9M | -$78.9M | -$60.5M | -$33.1M |
| Operating margin | — | — | — | — | -9511.9% | -3853.6% |
| Net income | -$26.4M | -$47.0M | -$66.7M | -$74.6M | -$57.8M | -$8.98M |
| Net margin | — | — | — | — | -9084.1% | -1046.4% |
| EPS (diluted) | -$1.52 | -$1.84 | -$2.09 | -$1.84 | -$10.61 | -$1.59 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$22.0M | -$45.5M | -$57.3M | -$60.3M | -$49.3M | -$29.8M |
| Capital expenditures | $137K | $333K | $54.0K | $12.0K | $0.00 | — |
| Free cash flow | -$22.2M | -$45.9M | -$57.3M | -$60.3M | -$49.3M | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $140M | $175M | $57.0M | $24.5M | $13.9M | $31.4M |
| Total assets | $142M | $182M | $180M | $116M | $68.1M | $62.3M |
| Total liabilities | $5.86M | $6.58M | $11.1M | $9.44M | $6.45M | $4.30M |
| Shareholders' equity | $136M | $176M | $169M | $106M | $61.7M | $58.0M |
| Retained earnings | -$47.0M | -$94.0M | -$161M | -$235M | -$293M | -$302M |
| Shares (wtd avg diluted) | 23.4M | 25.5M | 31.8M | 40.4M | 5.44M | 5.63M |
Every figure is extracted from Rallybio Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.